雅培，443亿美元

赛柏蓝器械01-26

作者 | 东台来源 | 赛柏蓝器械雅培最新财报发布，重点瞄准高增长市场。01全年销售额443.28亿美元医疗设备增长12.6%，糖尿病护理继续领跑近日，雅培发布2025全年财报。2025年雅培全年销售额总计443.28亿美元，基础业务（未包括新冠检测相关业务）的有机增长率为6.7%。其中，第四季度销售额为114.59亿美元，剔除新冠检测相关业务后，有机增长率为3.8%。增长主要得益于医疗设备和成熟...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2606223897?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-26 18:45","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2606223897","market":"us","top_or_hot":-1,"title":"雅培，443亿美元","media":"赛柏蓝器械","content":"<div>\n<p>作者 | 东台来源 | 赛柏蓝器械雅培最新财报发布，重点瞄准高增长市场。01全年销售额443.28亿美元医疗设备增长12.6%，糖尿病护理继续领跑近日，雅培发布2025全年财报。2025年雅培全年销售额总计443.28亿美元，基础业务（未包括新冠检测相关业务）的有机增长率为6.7%。其中，第四季度销售额为114.59亿美元，剔除新冠检测相关业务后，有机增长率为3.8%。增长主要得益于医疗设备和成熟...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126192006a6ae18f2&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>雅培，443亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n雅培，443亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-26 18:45 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126192006a6ae18f2&s=b><strong>赛柏蓝器械</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>作者 | 东台来源 | 赛柏蓝器械雅培最新财报发布，重点瞄准高增长市场。01全年销售额443.28亿美元医疗设备增长12.6%，糖尿病护理继续领跑近日，雅培发布2025全年财报。2025年雅培全年销售额总计443.28亿美元，基础业务（未包括新冠检测相关业务）的有机增长率为6.7%。其中，第四季度销售额为114.59亿美元，剔除新冠检测相关业务后，有机增长率为3.8%。增长主要得益于医疗设备和成熟...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126192006a6ae18f2&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0122379950.USD","symbol_name":"贝莱德世界健康科学A2","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126192006a6ae18f2&s=b","article_id":"2606223897","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126192006a6ae18f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2606223897","pubTimestamp":1769424330,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"01全年销售额443.28亿美元医疗设备增长12.6%，糖尿病护理继续领跑近日，雅培发布2025全年财报。2025年雅培全年销售额总计443.28亿美元，基础业务的有机增长率为6.7%。2025年诊断部门销售额89.37亿美元，同比下滑4.3%。其中体量最大的核心实验室销售额53.60亿美元，同比增长2.4%；快速诊断销售额24.54亿美元，同比下降18.1%。雅培发布的全年业绩指引显示，预计2026年有机销售额将增长6.5%至7.5%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0122379950.USD":"贝莱德世界健康科学A2","LU0234572021.USD":"高盛美国核心股票组合Acc","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU0058720904.USD":"联博国际健康护理基金A","LU1721429741.USD":"BNP PARIBAS SMART FOOD \"CRH\" (USD) INC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4581":"高盛持仓","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","ABT":"雅培","BK4585":"ETF&股票定投概念","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","SG9999002232.USD":"Allianz Global High Payout USD","BK4566":"资本集团","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","SGXZ41872573.SGD":"ALLIANZ SGD INCOME PLUS \"AM\" (SGD) INC","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","SG9999002224.SGD":"Allianz Global High Payout SGD","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","BK4504":"桥水持仓","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","BK4592":"伊斯兰概念","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","BK4082":"医疗保健设备","BK4568":"美国抗疫概念","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","BK4588":"碎股","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU1721429402.USD":"BNP PARIBAS SMART FOOD \"C\" (USD) ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC"},"translate_title":"Abbott, $44.3 billion","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":1.5},"content_text":"作者 | 东台来源 | 赛柏蓝器械雅培最新财报发布，重点瞄准高增长市场。01全年销售额443.28亿美元医疗设备增长12.6%，糖尿病护理继续领跑近日，雅培发布2025全年财报。2025年雅培全年销售额总计443.28亿美元，基础业务（未包括新冠检测相关业务）的有机增长率为6.7%。其中，第四季度销售额为114.59亿美元，剔除新冠检测相关业务后，有机增长率为3.8%。增长主要得益于医疗设备和成熟药品业务。分板块来看，2025医疗设备销售额213.87亿美元，同比增长12.6%。体量最大的糖尿病护理业务领跑增长。其中节律管理销售额26.49亿美元（+10.9%），电生理销售额27.64亿美元（+12.0%），心衰销售额14.48亿美元（+13.2%），血管销售额29.95亿美元（+5.6%），结构性心脏病销售额25.23亿美元（+12.3%），神经调节销售额10.10亿美元（+5.0%），糖尿病护理销售额79.98亿美元（+17.5%）。单季度看，雅培2025Q4医疗设备销售额按报告数据计算增长12.3%，按实际增长计算增长10.4%。季度增长主要得益于电生理学、心力衰竭、糖尿病护理和心律管理等领域的两位数增长。其中，连续血糖监测仪销售额达到20亿美元，按报告数据计算增长15.0%，按实际增长计算增长12.2%。2025年诊断部门销售额89.37亿美元，同比下滑4.3%。其中体量最大的核心实验室销售额53.60亿美元，同比增长2.4%；快速诊断销售额24.54亿美元，同比下降18.1%。剔除与新冠病毒检测相关的销售额后，全球核心实验室诊断业务2025Q4销售额按报告数据计算增长了5.3%，按有机增长计算增长了3.6%。而在其他地区所取得的成果，部分被中国市场的不利状况所抵消，其中包括带量采购的影响。雅培发布的全年业绩指引显示，预计2026年有机销售额将增长6.5%至7.5%。02跨国巨头，集体转向高增长领域数年间，跨国器械巨头们开启了一场向高增长、创新领域的集体转向。雅培方面表示，正在整个业务领域进行创新，重点瞄准高增长市场，并采取战略性举措以使公司能够实现长期发展。去年11月，雅培宣布将收购癌症筛查和精确肿瘤诊断领域的领导者Exact Sciences，预计该交易将在2026年第二季度完成。Exact Sciences专注于癌症的早期检测和支持个性化治疗，是癌症筛查、精确肿瘤学和基因检测领域的领导者，这项收购将帮助雅培在快速增长的癌症诊断市场中取得领先地位。电生理领域，近期雅培获得两项重要许可。一是美国电生理领域的业务拓展，Volt™PFA系统已获FDA批准，这也是雅培在美国推出的首款脉冲场消融设备。二是雅培旗下的TactiFlex™Duo消融导管获得CE认证，该导管通过射频和PFA能量为患有房颤的患者提供治疗。目前，电生理领域的PFA争夺战打得正酣。强生近期表示，期待在2026年将强生THERMOCOOL SMARTTOUCH SF双能导管提交给美国市场使用，预计接下来每年都会推出一款新的导管。近几年，强生反复强调要将业务组合转向更高创新度、更高增长性和更高利润率的市场。在最新的业绩说明会上，强生方面称，目前强生医疗科技近340亿美元的业务中，约有一半资产都处于高增长市场中，增长率超过5%。与2018年的约20%相比，这一比例显著提升。而在骨科拆分完成后，这一比例将进一步提升至70%。美敦力首席执行官Geoff Martha近期也表示，公司将以战略性并购主动出击，重点布局高增长且接近商业化的补强型并购标的。据悉，美敦力将聚焦于那些接近商业化阶段、具有高增长潜力的补强型并购领域。这一并购模式将聚焦与公司现有业务高度协同的中小型标的，旨在快速填补产品管线缺口、强化技术优势，与脉冲场消融技术、肾去神经化、急迫性尿失禁的胫骨神经调控以及手术机器人四大“世代增长驱动力”形成互补。当前，传统市场增速的日渐放缓与企业增长目标形成对抗，在增长压力与技术创新浪潮下，高增长的领域成为跨国巨头们的一大必选项。未来，医疗市场将更趋分化，精准诊断、微创治疗以及慢病管理等赛道有望持续增长，医学技术创新将继续向纵深发展。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2606223897","isCrawlerRequest":true}